BackAlphora Research Inc.
c/o Boris Gorin, Vice President, Research & Development
2395 Speakman Drive
Assets And Services
Alphora Research Inc. provides API (Active Pharmaceutical Ingredient) technology development services for the scale-up of complex small molecules for Pharmaceutical and Biotechnology companies. Our core focus is process chemistry and analytical services for early stage development of pre-clinical and clinical candidates, where speed and quality are paramount. As well, Alphora provides process chemistry expertise to later stage development programs where process economics, specifications, impurity profile characterization, regulatory strategies and supply chain management considerations are important. This focus provides Alphora's Client's with a complete and comprehensive API technology platform to meet the developmental requirements from pre-clinical through phase III and for the successful technology transfer to manufacturing locations throughout the world.
Prototyping and design
Alphora's strength is Process Chemistry and Analytical Development for the advancement of pre-clinical and clinical candidates, at all stages. Alphora combines excellence and creativity in synthetic organic chemistry with a sound scientific approach to analytical development in Active Pharmaceutical Ingredient technology creation. It is the application of this combined approach, with a long term view of the program requirements, that ensures the clients' clinical and commercial success.
Process Improvement and innovation eg. Automation, supply chain management, etc.
Synthetic scale-up development Analytical development and validation Gram to kilogram synthesis, both cGMP and non-GMP cGMP Chromatography Purification Stability testing Technology transfer services High potency and cytotoxic capabilities